Are type-2 biomarkers of any help in asthma diagnosis?
Haleh Nekoee, Emmanuel Graulich, Florence Schleich and 5 more
ERJ Open Research · 2020
doi:10.1183/23120541.00169-2020 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Asthma is a common chronic airway disease, the diagnosis of which remains challenging, as recently highlighted by the great proportion of both under- and overdiagnosis [1]. The current diagnosis is based on the conjunction of suggestive symptoms and the demonstration of an excessive airway calibre fluctuation either by a bronchodilation test or by a bronchial challenge [2, 3]. T2 biomarkers lack the accuracy to make an asthma diagnosis in patients with suggestive symptoms <https://bit.ly/3hYnnHu>
Abstract licence: CC BY-NC
References14
14 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.